Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study
| Autor: | Chase, Dana M., Sill, Michael W., Monk, Bradley J., Chambers, Mark D., Darcy, Kathleen M., Han, Ernest S., Buening, Barbara J., Sorosky, Joel I., Fruehauf, John P., Burger, Robert A. |
|---|---|
| Zdroj: | In Gynecologic Oncology September 2012 126(3):375-380 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect